Department of Public Health, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Infectious Diseases Unit, Diyarbakır Provincial Health Directorate, Diyarbakir, Turkey.
Influenza Other Respir Viruses. 2024 Sep;18(9):e70003. doi: 10.1111/irv.70003.
This study is aimed at providing information about the timing of booster doses and antibody kinetics in healthcare workers.
This research extends a prospective cohort study conducted at Dokuz Eylul University Hospital in Turkey, covering the period from March 2021 to December 2021. During this timeframe, the antibody levels of the health workers were measured at four different time points. The associations of antibody levels with gender, age, occupation, body mass index (BMI), chronic disease, and smoking were analyzed.
There was a significant difference between antibody levels in all four blood draws (p < 0.001). Antibody levels decreased in both those vaccinated with BNT162b2 (p < 0.001) and those vaccinated with CoronaVac (p = 0.002) until the fourth blood draw. There was a significant difference between those vaccinated with one and two doses of booster BNT162b2 before the third blood draw (p < 0.001), which continued at the fourth blood draw (p < 0.001). The antibody levels of those with an interval of 41-50 days between two vaccinations decreased significantly at the fourth blood draw (p < 0.001).
This study provides insight into the dynamics and persistence of antibody response after additional COVID-19 vaccine doses among healthcare workers. The longer the interval between booster doses may result in greater antibody levels being maintained over time, allowing for longer durations of protection.
本研究旨在提供有关医护人员加强针剂量和抗体动力学的信息。
本研究扩展了在土耳其多乌·泽伊内尔大学医院进行的一项前瞻性队列研究,涵盖了 2021 年 3 月至 2021 年 12 月期间。在此期间,医护人员的抗体水平在四个不同时间点进行了测量。分析了抗体水平与性别、年龄、职业、体重指数(BMI)、慢性疾病和吸烟之间的关系。
四次采血的抗体水平均存在显著差异(p<0.001)。接种 BNT162b2 和 CoronaVac 的人群的抗体水平均下降(p<0.001),直至第四次采血。第三次采血前接种一剂和两剂加强型 BNT162b2 的人群之间存在显著差异(p<0.001),第四次采血时仍存在显著差异(p<0.001)。第二次接种间隔 41-50 天的人群的抗体水平在第四次采血时显著下降(p<0.001)。
本研究提供了关于医护人员在接受额外 COVID-19 疫苗剂量后抗体反应的动态和持久性的见解。加强针剂量之间的间隔时间越长,可能会随着时间的推移保持更高的抗体水平,从而延长保护期。